RAPTOR PHARMACEUTICAL CORP's ticker is RPTP and the CUSIP is 75382F106. A total of 109 filers reported holding RAPTOR PHARMACEUTICAL CORP in Q3 2015. The put-call ratio across all filers is 1.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $628,000 | +119.6% | 69,952 | +31.4% | 0.01% | +160.0% |
| Q2 2016 | $286,000 | +61.6% | 53,252 | +38.8% | 0.01% | +25.0% |
| Q1 2016 | $177,000 | -94.5% | 38,378 | -93.8% | 0.00% | -88.2% |
| Q4 2015 | $3,238,000 | +145.7% | 622,654 | +185.9% | 0.03% | +161.5% |
| Q3 2015 | $1,318,000 | -57.0% | 217,808 | +12.3% | 0.01% | -53.6% |
| Q2 2015 | $3,063,000 | -22.4% | 193,987 | -46.6% | 0.03% | -28.2% |
| Q1 2015 | $3,947,000 | -0.3% | 363,113 | -3.5% | 0.04% | +56.0% |
| Q4 2014 | $3,959,000 | +42.0% | 376,411 | +29.4% | 0.02% | +92.3% |
| Q3 2014 | $2,789,000 | -14.1% | 290,778 | +3.4% | 0.01% | -13.3% |
| Q2 2014 | $3,248,000 | – | 281,220 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 7,000,000 | $32,200,000 | 3.11% |
| SV Health Investors, LLC | 888,132 | $4,085,000 | 3.05% |
| Sarissa Capital Management LP | 2,725,000 | $12,535,000 | 2.76% |
| GREAT POINT PARTNERS LLC | 1,346,344 | $6,193,000 | 2.22% |
| Virtus ETF Advisers LLC | 126,869 | $584,000 | 0.80% |
| SPHERA FUNDS MANAGEMENT LTD. | 400,000 | $1,840,000 | 0.40% |
| TFS CAPITAL LLC | 459,546 | $2,114,000 | 0.30% |
| GLOBEFLEX CAPITAL L P | 238,239 | $1,096,000 | 0.29% |
| TURNER INVESTMENTS LLC | 161,100 | $741,000 | 0.20% |
| Birchview Capital, LP | 40,000 | $184,000 | 0.13% |